Evidence map›Paper›PMID 32135142›Full record

ArticleAmerican journal of obstetrics and gynecology2020

Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia.

Lisa Bedford, Samantha E Parker, Elyse Davis, Elizabeth Salzman, Sharon L Hillier, Betsy Foxman, Bernard L Harlow

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05478746 (Effects of Flourish HEC Vaginal Care System on Reduction of Pain in Women With Localized Provoked Vulvodynia), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05478746 nacompletednot on this mapstarted 2022, after this paper: background citation

Effects of Flourish HEC Vaginal Care System on Reduction of Pain in Women With Localized Provoked Vulvodynia

TypeinterventionalSponsorVaginal Biome ScienceRan2022 to 2024Enrolled7ConditionsVulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar VestibulitisArmsBioNourish, a component of the Flourish HEC kit, Control - no intervention
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Menstrual Cycle Characteristics and Vulvodynia.Journal of women's health (2002) · 2022
    Article
  7. Article
  8. Article
  9. Vulvodynia Is Not Associated with Concurrent Candidal Vaginitis.Women's health reports (New Rochelle, N.Y.) · 2022
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lisa BedfordDepartment of Epidemiology, Boston University School of Public Health, Boston, MA.
Samantha E ParkerDepartment of Epidemiology, Boston University School of Public Health, Boston, MA.
Elyse DavisDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI.
Elizabeth SalzmanDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI.
Sharon L HillierDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, and the Magee-Women's Research Institute, Pittsburgh, PA.
Betsy FoxmanDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI.
Bernard L HarlowDepartment of Epidemiology, Boston University School of Public Health, Boston, MA. Electronic address: harlow@bu.edu.
University of Michigan · USBoston University · USUniversity of Pittsburgh · US

Funding

Immunological Factors and Risk of VulvodyniaR01HD058608 · NICHD · UNIVERSITY OF MINNESOTA · PI HARLOW, BERNARD L · 2009 to 2013
$3.1M
NICHD NIH HHS R01 HD058608
6 · The paper itself

Abstract

backgroundVulvodynia (idiopathic vulvar pain) affects up to 8% of women by age 40 years, has a poorly understood etiology, and has variable treatment efficacy. Several risk factors are associated with vulvodynia from a history of yeast infections to depression and allergies. Recent work suggests an altered immune inflammatory mechanism plays a role in vulvodynia pathophysiology. Because the vaginal microbiome plays an important role in local immune-inflammatory responses, we evaluated the vaginal microbiome among women with vulvodynia compared with controls as 1 component of the immune system.

objectiveThe objective of the study was to characterize the vaginal microbiome in women with clinically confirmed vulvodynia and age-matched controls and assess its overall association with vulvodynia and how it may serve to modify other factors that are associated with vulvodynia as well. STUDY

designWe conducted a case-control study of 234 Minneapolis/Saint Paul-area women with clinically confirmed vulvodynia and 234 age-matched controls clinically confirmed with no history of vulvar pain. All participants provided vulvovaginal swab samples for culture-based and non-culture (sequencing)-based microbiological assessments, background and medical history questionnaires on demographic characteristics, sexual and reproductive history, and history of psychosocial factors. Vaginal microbiome diversity was assessed using the Shannon alpha diversity Index. Data were analyzed using logistic regression.

resultsCulture and molecular-based analyses of the vaginal microbiome showed few differences between cases and controls. However, among women with alpha diversity below the median (low), there was a strong association between increasing numbers of yeast infections and vulvodynia onset, relative to comparable time periods among controls (age-adjusted odds ratio, 8.1, 95% confidence interval, 2.9-22.7 in those with 5 or more yeast infections). Also among women with low-diversity microbiomes, we observed a strong association between moderate to severe childhood abuse, antecedent anxiety, depression, and high levels of rumination and vulvodynia with odds ratios from 1.83 to 2.81. These associations were not observed in women with high-diversity microbiomes.

conclusionAlthough there were no overall differences in microbiome profiles between cases and controls, vaginal microbiome diversity influenced associations between environmental and psychosocial risk factors and vulvodynia. However, it is unclear whether vaginal diversity modifies the association between the risk factors and vulvodynia or is altered as a consequence of the associations.

Indexed as

AdolescentAdultBacteriaCandidiasis, VulvovaginalCase-Control StudiesContraceptive Agents, HormonalFemaleHumansMicrobiotaMinnesotaPsychologyRNA, Ribosomal, 16SSexual PartnersVaginaVulvodyniaYoung AdultContraceptive Agents, HormonalRNA, Ribosomal, 16Scase-control studiesmicrobiomevulvodyniayeast infections

Identifiers

PMID32135142
PMCPMC10027365
OpenAlexW3009926025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.